抄録
We studied about the skin safety and clinical evaluation of 0.1% Hydrocortisone 17-butyrate 21 -propionate (HBP). 40 patients with skin diseases were patch tested with HBP ointment, cream, ointment base and cream base. And skin irritation indices were calicurated as 2. 5, 1. 25, 1. 75 and 1. 84 respectively. 2 patients were reacted to methyl paraben formulated in the crem base as a preservative. 41 patients with skin diseases were treated with HBP ointment. The patients applied HBP ointment simply to their lesions three times a day. 14 cases out of the 41 patients (34. 2%) were completely cured and 19 cases (46. were well improved within three weeks. Side effect was shown in one case.
| 本文言語 | 英語 |
|---|---|
| ページ(範囲) | 130-138 |
| ページ数 | 9 |
| ジャーナル | [Hifu] Skin research |
| 巻 | 26 |
| 号 | 1 |
| DOI | |
| 出版ステータス | 出版済み - 1984 |
| 外部発表 | はい |
UN SDG
この成果は、次の持続可能な開発目標に貢献しています
-
SDG 3 すべての人に健康と福祉を
All Science Journal Classification (ASJC) codes
- 皮膚病学
- 感染症
フィンガープリント
「Skin Safety and Clinical Evaluation of 0.1% Hydrocortisone 17-butyrate 21-propionate (HBP)」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。引用スタイル
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver